Alzheimer's disease: overview

doi:10.1017/CBO9780511544873.029

28 - Alzheimer's disease: overview

from Part IV - Alzheimer's disease

Published online by Cambridge University Press: 04 August 2010

Anthony E. Lang and

Keith A. Josephs and

M. Flint Beal: Affiliation:
Cornell University, New York
Anthony E. Lang: Affiliation:
University of Toronto
Albert C. Ludolph: Affiliation:
Universität Ulm, Germany
David F. Tang-Wai: Affiliation:
Division of Neurology, University Health Network, Toronto Western Hospital, Canada
Keith A. Josephs: Affiliation:
Division of Neurology, University Health Network, Toronto Western Hospital, Canada
Ronald C. Petersen: Affiliation:
Division of Neurology, University Health Network, Toronto Western Hospital, Canada

Book contents

Get access

Summary

Dementia

Dementia, itself, neither implies a specific disease nor implies a specific underlying pathology. It refers to a change in cognitive function that is severe enough to compromise an individual's daily function. The Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) defines dementia as an acquired impairment of cognitive function that includes a decline in memory beyond what would be expected for age and at least one other cognitive function, such as attention, visuospatial skills or language, or a decline in executive functioning such as planning, organization, sequencing, or abstracting. The decline cannot only affect emotional abilities, but must also interfere with work or social activities. The deficits should not be accompanied by an impairment of arousal (delirium) or be accounted for by another psychiatric condition, such as depression or schizophrenia. Dementia can further be defined by a possible, probable, or definite etiologic diagnosis. A degenerative dementia implies disease progression over time.

While the DSM-IV criteria are generally useful, one problem with the criteria is that memory impairment is an essential feature. While this is common in most dementias, other dementias may present with impairment in a non-memory cognitive domain. If the initial presentation is a change in personality or behavior, rather than memory, a frontotemporal dementia may be the diagnosis. In subjects with parkinsonism, hallucinations and fluctuations in behavior, dementia with Lewy bodies may be more likely than AD.

Type: Chapter
Information: Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 416 - 432

DOI: https://doi.org/10.1017/CBO9780511544873.029 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Alzheimer's Disease Collaborative Group (1995). The structure of the presenilin 1 (S1282) gene and identification of six novel mutations in early onset AD families. Nat. Genet., 11, 219–22CrossRef

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association

Andreasen, N., Hesse, C., Davidsson, P.et al. (1999a). Cerebrospinal fluid beta-amyloid(1–42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol., 56, 673–80CrossRef Google Scholar

Andeasen, N., Minthon, L., Clarberg, A.et al. (1999b). Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology, 53, 1488–94CrossRef Google Scholar

Arai, H., Higuchi, S. & Saskai, H. (1997). Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease. Gerontology, 43 (suppl 1), 2–10CrossRef Google Scholar PubMed

Bachman, D. L., Wolf, P. A., Linn, R.et al. (1992). Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology, 42, 115–19CrossRef Google Scholar PubMed

Bartenstein, P., Minoshima, S., Hirsch, C.et al (1997). Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J. Nucl. Med., 38, 1095–101Google Scholar PubMed

Baskin, F., Rosenberg, R. N., Iyler, L., Hynan, L. & Cullum, C. M. (2000). Platelet APP isoform ratios correlate with declining cognition in AD. Neurology, 54 (10), 1907–9CrossRef Google Scholar PubMed

Becker, P. M., Feussner, J. R., Mulrow, C. D., Williams, B. C.& Vokaty, K. A. (1985). The role of lumbar puncture in the evaluation of dementia: the Durham Veterans Administration/Duke University Study. J. Am. Geriat. Soc., 33, 392–6CrossRef Google Scholar PubMed

Benson, D. F., Davis, R. J. & Snyder, B. D. (1988). Posterior cortical atrophy. Arch. Neurol., 45 (7), 789–93CrossRef Google Scholar PubMed

Blessed, G., Tomlinson, B. E. & Roth, M, . (1968). The association between quantitative measures of dementia and of senile changes in the cerebral gray matter of elderly subjects. Br. J. Psychiat., 114, 797–811CrossRef Google Scholar

Boeve, B. F., Maraganore, D. M., Parisi, J. E.et al. (1999). Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology, 53, 795–800CrossRef Google Scholar PubMed

Borroni, B., Colciaghi, F., Pastorino, L.et al. (2001). Amyloid precursor protein in platelets of patients with Alzheimer's disease: effect of acetylcholinerase inhibitor treatment. Arch. Neurol., 58, 442–6CrossRef Google Scholar

Bowen, D. M., Smith, C. B., White, P. & Davison, A. N. (1976). Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain, 99, 459–96CrossRef Google Scholar PubMed

Bradley, K. M., O'Sullivan, V. T., Soper, N. D. W.et al. (2002). Cerebral perfusion SPECT correlated with Braak pathological stage in Alzheimer's disease. Brain, 2002; 125, 1772–81CrossRef Google Scholar PubMed

Brookmeyer, R., Gray, S. & Kawas, C, . (1998). Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Hlt., 88, 1337–42CrossRef Google Scholar PubMed

Bush, A. I., Martins, R. N., Rumble, B.et al. (1990). The amyloid precursor protein of Alzheimer's disease is released by human platelets. J. Biol. Chem., 265 (26), 15977–83Google Scholar PubMed

Canadian Study of Health and Aging (1994). Study methods and prevalence of dementia. Can. Med. Assoc. J., 150, 899–913

Caselli, R. J. (1995). Focal and asymmetric cortical degeneration syndromes. The Neurologist, 1 (1), 1–19Google Scholar

Chung, J. A. & Cummings, J. L. (2000). Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment. Neurologic Clinics, 18 (4), 829–46CrossRef Google Scholar PubMed

Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L. & Ueland, P. M. (1998). Folate, vitamin B12, and total homocyteine levels in confirmed Alzheimer's disease. Arch. Neurol., 55, 1449–55CrossRef Google Scholar

Clauss, J. J., Harskamp, F., Breteler, M. M.et al. (1994). The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology, 44, 454–61CrossRef Google Scholar

Corder, E. H., Saunders, A. M., Strittmatter, W. J.et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset-families. Science, 261, 921–3CrossRef Google Scholar PubMed

Corder, E. H., Saunders, A. M., Risch, N. J.et al. (1994). Protective effect of apolipoprotein E allele 2 for late onset Alzheimer's disease. Nat. Genet., 7, 180–4CrossRef Google Scholar

Cummings, J. L. & Cole, G. (2002). Alzheimer's disease. J. Am. Med. Assoc., 287 (18), 2335–8CrossRef Google Scholar

Davies, P. & Maloney, A. J. (1976). Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 4, 1403CrossRef Google Scholar

Monte, S. M. & Wands, J. (1992). Neuronal thread protein overexpression in brains with Alzheimer's disease lesions. J. Neurol. Sci., 113, 153–64Google Scholar

Monte, S. M., Volicer, L., Hauser, S. L. & Wands, J. R. (1992). Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol., 32, 733–42CrossRef Google Scholar PubMed

Monte, S. M., Ghanbari, K., Frey, W. H.et al. (1997). Characterization of the AD7C-NTP DNAcDNA expression in Alzheimer's disease and measurement of a 41-kD protein in the cerebrospinal fluid. J. Clin. Invest., 100 (12), 3093–104CrossRef Google Scholar PubMed

Dickson, D. W. (1999). Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J. Neurol., 246 (S2), 6–15CrossRef Google Scholar PubMed

Di Luca, M., Pastorino, L., Bianchetti, A.et al. (1998). Differential levels of platelet amyloid β precursor protein isoforms. Arch. Neurol., 55, 1195–200CrossRef Google Scholar PubMed

Dodart, J. C., Bales, K. R., Gannon, K. S.et al. (2002). Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model. Nat. Neurosci., 5 (5), 452–7CrossRef Google Scholar PubMed

Doody, R. S., Stevens, J. C., Beck, C.et al.Practice parameter: management of dementia (an evidence-based review), Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1154–66CrossRef

Ertekin-Taner, N., Graff-Radford, N., Younkin, L. H.et al. (2000). Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science, 290 (5500), 2303–4CrossRef Google Scholar PubMed

Evans, D. A., Funkenstein, H. H., Albert, M. S.et al. (1989). Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. J. Am. Med. Assoc., 262, 2551–6CrossRef Google Scholar

Evans, D. A., Hebert, L. E., Beckett, L. A.et al.Education and other measures of socioeconomic status and risk of incipient Alzheimer's disease in a defined population of older persons. Arch. Neurol., 54, 1399–1405CrossRef

Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975). ‘Mini-Mental State’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res., 12, 189–98CrossRef Google Scholar

Förstl, H. & Levy, R. (1991). On certain peculiar diseases of old age. Hist. Psychiatr., 2 (5, 1), 71–101Google Scholar

Fox, N. C., Warrington, E. K., Freeborough, P. A.et al. (1996). Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal study. Brain, 119 (6), 2001–7CrossRef Google Scholar

Fox, N. C., Scahill, F. I., Crum, W. R. & Rossor, M. N. (1999). Correlation between rates of brain atrophy and cognitive decline in AD. Neurology, 52 (8), 1687–9CrossRef Google Scholar PubMed

Fox, N. C., Crum, W. R., Scahill, R. I., Stevens, J. M., Janssen, J. C. & Rossor, M. N. (2001). Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet, 358 (9277), 201–5CrossRef Google Scholar PubMed

Fratiglioni, L., Albom, A., , M.iitanen & Winblad, B. (1993). Risk factors for late-onset Alzheimer's disease. Ann. Neurol., 33, 258–66CrossRef Google Scholar PubMed

Galasko, D., Hansen, L. A., Katzman, R.et al. (1994). Clinical–neuropathological correlations in Alzheimer's disease and related dementias. Arch. Neurol., 51 (9), 888–95CrossRef Google Scholar PubMed

Galasko, D., Clark, C., Chang, L.et al. (1997). Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology, 48, 632–5CrossRef Google Scholar PubMed

Galasko, D., Chang, L., Motter, R.et al. (1998). High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch. Neurol., 55, 937–45CrossRef Google Scholar PubMed

Galton, C. J., Patterson, K., Xuereb, J. H. & Hodges, J. R. (2000). Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain, 123, 484–98CrossRef Google Scholar PubMed

Gao, S., Hendrie, H. C., Hall, K. S. & Hui, S. (1998). The relationships between age, sex, and the incidence of dementia and Alzheimer's disease. Arch. Gen. Pyschiatr., 55, 809–15CrossRef Google Scholar

Garrard, P. & Hodges, J. R. (2000). Semantic dementia: clinical, radiological and pathological perspectives. J. Neurol., 247, 409–22CrossRef Google Scholar PubMed

Gearing, M., Mirra, S. S., Hedreen, J. C., Sumi, S. M., Hansen, L. A. & Heyman, A. (1995). The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology, 45, 461–6CrossRef Google Scholar

Ghanbari, H., Ghanbari, K., Beheshti, I., Munzar, M., Vasauskas, A. & Averback, P. (1998). Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker. J. Clin. Lab. Anal., 12, 285–83.0.CO;2-5>CrossRef Google Scholar PubMed

Graff-Radford, N. R., Green, R. C., Go, R. C.et al. (2002). Association between apolipoprotein E genotype and Alzheimer's disease in African American subjects. Arch. Neurol., 59 (4), 594–600CrossRef Google Scholar PubMed

Green, R. C., Cupples, L. A., Kurz, A.et al. (2003). Depression as a risk factor for Alzheimer's disease: the MIRAGE study. Arch. Neurol., 60, 753–9CrossRef Google Scholar PubMed

Guo, Z., Cupples, L. A., Kurz, A.et al. (2000). Head injury and the risk of AD in the MIRAGE study. Neurology, 54, 1316–23CrossRef Google Scholar PubMed

Hardy, J. & Gwinn-Hardy, K. 1998). Genetic classification of primary neurodegenerative disease. Science, 282, 1075–9CrossRef Google Scholar PubMed

Henderson, V. W., Paganini-Hill, A., Miller, B. L.et al. (2000). Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology, 54 (2), 295–301CrossRef Google Scholar PubMed

Hendrie, H. C., Osuntokun, B. O., Hall, K. S.et al. (1995). Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am. J. Psychiatr., 152, 1485–92Google Scholar PubMed

Hodges, J. R., Patterson, K., Oxbury, S. & Funnell, E. (1992). Semantic dementia. Brain, 115, 1783–806CrossRef Google Scholar PubMed

Hof, P. R., Vogt, B. A., Bouras, C. & Morrison, J. H. (1997). Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res., 37 (24), 3609–25CrossRef Google Scholar PubMed

Hofman, A., Ott, A., Breteler, M. M.et al. (1997). Atherosclerosis, apolipoprotein E and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet, 349, 151–4CrossRef Google Scholar PubMed

Hulstaert, F., Blennow, K., Ivanoiu, A.et al. (1999). Improved discrimination of AD patients using beta-amyloid(1–42) and tau levels in CSF. Neurology, 52, 1555–62CrossRef Google Scholar PubMed

Hussain, I., Powell, D., Howlett, D. R.et al. (1999). Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell Neurosci., 14, 419–27CrossRef Google Scholar PubMed

in't Veld, B. A., Ruitenberg, A., Hofman, A.et al. (2001). Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med., 325 (21), 1515–21CrossRef Google Scholar

Jack, C. R. Jr, Petersen, R. C., Xu, Y. C.et al. (1997). Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology, 49, 786–94CrossRef Google Scholar PubMed

Jack, C. R. Jr, Petersen, R. C., Xu, Y. C.et al. (1999). Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology, 52, 1397–403CrossRef Google Scholar PubMed

Jack, C. R., Dickson, D. W., Parisi, J. E.et al. (2002). Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology, 58, 750–7CrossRef Google Scholar PubMed

Jagust, W., Thisted, R., Devous, M. D. Sr.et al. (2001). SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study. Neurology, 56, 950–6CrossRef Google Scholar

Johnson, K. A., Holman, B. L., Rosen, T. J., Nagel, J. S., English, R. J. & Growdon, J. H. (1990). Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Arch. Intern. Med., 150, 752–6CrossRef Google Scholar

Johnson, K. A., Kijewski, M., Becker, J., Garada, B., Satlin, A. & Holman, B. L. (1993). Quantitative brain SPECT in Alzheimer's disease and normal aging. J. Nucl. Med., 34, 2044–8Google Scholar PubMed

Kahle, P. J., Jakowec, M., Teipel1, S. J.et al. (2000). Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology, 54, 1498–504CrossRef Google Scholar PubMed

Katzman, R., Brown, T., Fuld, P., Peck, A., Schechter, R. & Schimmel, H. (1983). Validation of a short orientation-memory-concentration test of cognitive impairment. Am. J. Psychiatr., 140, 734–9Google Scholar

Killiany, R. J., Gomez-Isla, T., Moss, M.et al. (2000). Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann. Neurol., 47, 430–93.0.CO;2-I>CrossRef Google Scholar PubMed

Klünem ann, H. H., Fronhöfer, W., Wurster, H., Fischer, W., Ibach, B. & Klein, H. E. (2002). Alzheimer's second patient: Johann F and his family. Ann. Neurol., 52, 520–3CrossRef Google Scholar

Knopman, D. S., DeKosky, S. T., Cummings, J. L.et al. (2001). Practice parameter: diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology, 56, 1143–53CrossRef Google Scholar PubMed

Kokmen, E., Beard, C. M., Offord, K. & Kurland, L. T. (1989). Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975. Neurology, 39, 773–6CrossRef Google Scholar

Kokmen, E., Smith, G. E., Petersen, R. C., Tangalos, E. & Ivnik, R. J. (1991). The short test of mental status: correlations with standardized psychometric testing. Arch. Neurol., 48, 725–8CrossRef Google Scholar PubMed

Kokmen, E. K., Beard, C. M., O'Brien, P. C. & Kurland, L. T. (1996). Epidemiology of dementia in Rochester, Minnesota. Mayo Clin. Proc., 71, 275–82CrossRef Google Scholar PubMed

Kramer, J. H. & Miller, B. L. (2000). Alzheimer's disease and its focal variants. Sem. Neurol., 20 (4), 447–54CrossRef Google Scholar PubMed

Kukull, W. A. & Ganguli, M. (2000). Epidemiology of dementia: concepts and overview. In Neurologic Clinics ed. S. DeKosky, Vol. 18, pp. 923–49. Philadelphia: W. B. SaundersCrossRef

Kurz, A., Riemenschneider, M., Buch, K.et al. (1998). Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease. Alzheimer Dis. Assoc. Disord., 12, 372–7CrossRef Google Scholar PubMed

Launer, L. J., Andersen, K., Dewey, M. E.et al. (1999). Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology, 52, 78–84CrossRef Google Scholar

Lee, V. Y. M., Goedert, M. & Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Ann. Rev. Neurosci., 24, 1121–59CrossRef Google Scholar PubMed

Levine, D. N., Lee, J. M. & Fisher, C. M. (1993). The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology, 43 (2), 305–13CrossRef Google Scholar PubMed

Machulda, M. M., Ward, H. A., Borowski, B.et al. (2003). Comparison of memory fMRI response among normal, MCI and Alzheimer's patients. Neurology, 61, 500–6CrossRef Google Scholar PubMed

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. & Stadlan, E. M. (1984). Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–44CrossRef Google Scholar PubMed

Mesulam, M. M. (1982). Slowly progressive aphasia without generalized dementia. Ann. Neurol., 11, 592–8CrossRef Google Scholar PubMed

Mesulam, M. M. (2001). Primary progressive aphasia. Ann. Neurol., 49, 425–32CrossRef Google Scholar PubMed

Mohs, R. C., Doody, R. S., Morris, J. C.et al. (2001). A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology, 57, 481–8CrossRef Google Scholar PubMed

Morris, J. C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43, 2412–14CrossRef Google Scholar PubMed

Mortimer, J. A. (1995). The epidemiology of Alzheimer's Disease: Beyond risk factors. In Research Advances in Alzheimer's Disease and Associated Disorders, ed. I. Iqbal, J. Mortimer, B. Winblad & H. Wisniewski. Chichester, UK: John Wiley

Müller, W. E., Mutschler, E. & Riederer, P. (1995). Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia. Pharmacopsychiatry, 28, 113–24CrossRef Google Scholar PubMed

Mulnard, R. A., Cotman, C. W., Kawas, C.et al. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. J. Am. Med. Assoc., 283 (8), 1007–15CrossRef Google Scholar PubMed

Munoz, D. & Feldman, H. (2002). Causes of Alzheimer's disease. Can. Med. Assoc. J., 162 (1), 65–72Google Scholar

Nicoll, J. A., Wilkinson, D., Holmes, C., Steart, P., Markham, H. & Weller, R. O. (2003). Neuropathology of human Alzheimer's disease following immunization with amyloid beta peptide: a case report. Nat. Med., 9, 448–52CrossRef Google Scholar PubMed

Orgogozo, J. M., Gilman, S., Dartigues, J. F.et al. (2003). Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology, 61, 46–54CrossRef Google Scholar

Padovani, A., Borroni, B., Colciaghi, F.et al. (2001). Platelet amyloid precursor protein forms in AD: a peripheral diagnostic and pharmacological target. Mech. Aging Devel., 122, 1997–2004CrossRef Google Scholar PubMed

Petersen, R. C. (1977). Scopolamine induced learning failures in man. Psychopharmacology, 52, 283–9CrossRef Google Scholar PubMed

Pfiefer, M., Boncristiano, S., Bondolfi, L.et al. (2002). Cerebral hemorrhage after passive anti-Ab immunotherapy. Science, 298, 1379CrossRef Google Scholar

Qiu, C., Winblad, B., Fastbom, J. & Fratiglioni, L. (2003). Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. Neurology, 61, 655–60CrossRef Google Scholar PubMed

Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S. & Möbius, H. J. (2003). Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med., 348, 1333–41CrossRef Google Scholar PubMed

Rogers, S., Farlow, M., Doody, R., Mohs, R. & Friedhoff, L. D. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology, 50, 136–45CrossRef Google Scholar PubMed

Rosler, M., Anand, R., Cicin-Sain, A.et al. (1999). Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. B. Med. J., 318, 633–8CrossRef Google Scholar PubMed

Ross Mackenzie, S. J., Graham, N., Stuart-Green, L.et al. (1996). Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr., 61 (4), 388–95CrossRef Google Scholar

Sano, M., Ernesto, C., Thomasm, R.et al. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med., 336, 1216–22CrossRef Google Scholar PubMed

Saunders, A. M., Strittmatter, W. J., Schmechel, D.et al. (1993). Association of apolipoprotein E allele 4 with late onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467–72CrossRef Google Scholar PubMed

Schenk, D., Barbour, R., Dunn, W.et al. (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400, 173–7CrossRef Google Scholar PubMed

Schenk, D. (2002). Opinion. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Nat. Rev. Neurosci., 3, 824–8CrossRef Google Scholar

Selkoe, D. J. (2000). The genetics and molecular pathology of alzheimer's disease: roles of amyloid and the presenilins. In Neurologic Clinics, ed. S. DeKosky, pp. 903–21. Vol. 18. Philadelphia: W. B. SaundersCrossRef

Senior, K. (2002). Dosing in phase II trial of Alzheimer's vaccine suspended. Lancet Neurol. 1, 3CrossRef Google Scholar PubMed

Seshadri, S., Drachman, D. A. & Lippa, C. F. (1995). Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer's disease. Arch. Neurol., 52, 1074–9CrossRef Google Scholar

Seshadri, S., Beiser, A., Selhub, J.et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med., 346 (7), 476–83CrossRef Google Scholar PubMed

Sherrington, R., Rogaev, E. I., Liang, Y.et al. (1995). Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature, 375, 754–60CrossRef Google Scholar

Shoji, M., Matsubara, E., Kanai, M.et al. (1998). Combination assay of CSF tau, A beta 1–40 and A beta 1–42(43) as a biochemical marker of Alzheimer's disease. J. Neurol. Sci., 158, 134–40CrossRef Google Scholar

Shumaker, S. A., Legault, C., Rapp, S. R.et al. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. J. Am. Med. Assoc., 289, 2651–62CrossRef Google Scholar PubMed

Sinha, S., Anderson, J. P., Barbour, R.et al. (1999). Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature, 402, 537–40CrossRef Google Scholar PubMed

Small, G., Rabins, P., Barry, P.et al. (1997). Diagnosis and treatment of Alzheimer's disease and related disorders. Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. J. Am. Med. Assoc., 278, 1363–71CrossRef Google Scholar

Spillantini, M. G. & Goedert, M. (1998). Tau protein pathology in neurodegenerative diseases. Trends Neurosci., 21, 428–33CrossRef Google Scholar PubMed

St. George-Hyslop, P. H., Levesque, G., Levesque, L., Rommens, J., Westaway, D. & Fraser, P. E. (1996). Two homologous genes causing early-onset familial Alzheimer's disease. Cold Spring Harbor Symp. Quant. Biol., 61, 559–64Google Scholar PubMed

Stelzmann, R. A., Schnitzlein, H. N. & Murtagh, F. R. (1995). An English translation of Alzheimer's 1907 paper ‘Über eine eigenartige Erkankung der Hirnrinde’. Clin. Anat., 8 (6), 429–31CrossRef Google Scholar

Tang-W ai, D. F., Josephs, K. A., Boeve, B. F., Dickson, D. K., Parisi, J. E. & Petersen, R. C. (2003a). Coexistent Lewy body disease in a case of ‘visual variant Alzheimer's disease’. J. Neurol. Neurosurg. Psychiatr., 74, 389CrossRef Google Scholar

Tang-W ai, D. F., Josephs, K. A., Boeve, B. F., Dickson, D. K., Parisi, J. E. & Petersen, R. C. (2003b). Pathologically confirmed corticobasal degneration presenting with visuospatial dysfunction. Neurology, 61 (8), 1134–5CrossRef Google Scholar

Tang-W ai, D. F., Graff-Radford, N. R., Boeve, B. F.et al. (2003c). Clinical and neuropathological characteristics of posterior cortical atrophy. Neurology, 60, A264–5Google Scholar

Tariot, P. N., Solomon, P. R., Morris, J. C., Kershaw, P., Lilienfeld, S. & Ding, C. (2000). A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology, 54, 2269–76CrossRef Google Scholar PubMed

Tekin, S. & Cummings, J. L. (2001). Depression in dementia. The Neurologist, 7, 252–9CrossRef Google Scholar

Teng, E. L. & Chui, H. C. (1987). The Modified Mini-Mental State (3MS) examination. J. Clin. Psychiatr., 48, 314–18Google Scholar PubMed

The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med., 330 (15), 1029–35CrossRef

The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group (1998). Consensus report of the Working Group on: molecular and biochemical markers of Alzheimer's disease. Neurobiol. Agin., 19 (2), 109–16

Gool, W. A., Walstra, G. J., Teunisse, S., Zant, F. M., Weinstein, H. C. & Royen, E. A. (1995). Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography. J. Neurol., 242, 401–5CrossRef Google Scholar PubMed

Slegtenhorst, M., Lewis, J. & Hutton, M. (2000). The molecular genetics of the tauopathies. Exp. Geront., 35, 461–71CrossRef Google Scholar PubMed

Vassar, R., Bennett, B. D., Babu-Khan, S.et al. (1999). Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 286, 735–41CrossRef Google Scholar PubMed

Victoroff, J., Ross, G. W., Benson, D. F., Verity, M. A. & Vinters, H. V. (1994). Posterior cortical atrophy, Neuropathologic correlations. Arch. Neurol., 51 (3), 269–74CrossRef Google Scholar PubMed

Strauss, E., , iitanen, M., Ronchi, D., Winblad, B. & Fratiglioni, L. (1999). Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch. Neurol., 56, 587–92CrossRef Google Scholar

White, L., Petrovitch, H., Ross, G. W.et al. (1996). Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. J. Am. Med. Assoc., 276, 955–60CrossRef Google Scholar PubMed

Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T. & DeLong, M. R. (1981). Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol., 10, 122–6CrossRef Google Scholar PubMed

Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T. & Delon, M. R. (1982). Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237–9CrossRef Google Scholar PubMed

Winblad, B. & Poritis, N. (1999). Memantine in severe dementia: results of the 9M-BEST study (benefit and efficacy in severely demented patients during treatment with memantine). Int. J. Geriat. Psychiatr., 14, 135–463.0.CO;2-0>CrossRef Google Scholar

Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G. G. & Siegel, G. (2000). Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch. Neurol., 57, 1439–43CrossRef Google Scholar

Xu, Y., Jack, C. R. Jr, O'Brien, P. C.et al. (2000). Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology, 54, 1760–7CrossRef Google Scholar PubMed

Yan, R., Bienkowski, M. J., Shuck, M. E.et al. (1999). Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature, 402, 533–7CrossRef Google Scholar PubMed

Zandi, P. P., Carlson, M. C., Plassman, B. L.et al. (2002). Hormone replacement therapy and the incidence of Alzheimer's disease in older women: the Cache County study. J. Am. Med. Assoc., 288, 2123–9CrossRef Google Scholar PubMed

Zubenko, G. S., Zubenko, W. N., McPherson, S.et al. (2003). A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am. J. Psychiatr., 160 (5), 857–66CrossRef Google Scholar PubMed